Subtype-specific mutations drive relapse risk in most common childhood leukemia
November 02, 2026
November 02, 2026
MEMPHIS, Tennessee, Nov. 2 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
Subtype-specific mutations drive relapse risk in most common childhood leukemia
*
Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment -- and genetic changes present from the start may help explain why. Scientists at St. Jude Children's Resea . . .
* * *
Subtype-specific mutations drive relapse risk in most common childhood leukemia
*
Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment -- and genetic changes present from the start may help explain why. Scientists at St. Jude Children's Resea . . .